The use of autologous platelet-rich fibrin matrix combined with meniscal repair in the treatment of parameniscal cyst: clinical results and cyst recurrence after 2-year of follow up

Abstract Purpose Parameniscal cysts are associate with horizontal meniscal tears. Arthroscopic meniscal repair and the excision of the cyst by mini-open approach represent a valid treatment. However, the recurrence of cyst is still a current issue. Therefore, biological factors may be considered to...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Daniele Screpis, Gianluca Piovan, Simone Natali, Stefano Pasqualotto, Stefano Magnanelli, Venanzio Iacono, Luca Farinelli, Marco Grassi, Claudio Zorzi
Formato:	article
Lenguaje:	EN
Publicado:	SpringerOpen 2021
Materias:	Parameniscal cyst, PRP membrane All-inside suture PRP augmentation Orthopedic surgery RD701-811
Acceso en línea:	https://doaj.org/article/cb33ebd17fe148f987b2809e794321cd
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:cb33ebd17fe148f987b2809e794321cd
record_format	dspace
spelling	oai:doaj.org-article:cb33ebd17fe148f987b2809e794321cd2021-12-05T12:17:38ZThe use of autologous platelet-rich fibrin matrix combined with meniscal repair in the treatment of parameniscal cyst: clinical results and cyst recurrence after 2-year of follow up10.1186/s40634-021-00423-12197-1153https://doaj.org/article/cb33ebd17fe148f987b2809e794321cd2021-11-01T00:00:00Zhttps://doi.org/10.1186/s40634-021-00423-1https://doaj.org/toc/2197-1153Abstract Purpose Parameniscal cysts are associate with horizontal meniscal tears. Arthroscopic meniscal repair and the excision of the cyst by mini-open approach represent a valid treatment. However, the recurrence of cyst is still a current issue. Therefore, biological factors may be considered to promote the biological repair and avoid recurrence. The aim of the present study was to report the clinical results and the rate of recurrence of the cyst after minimum 2-year of follow up in a cohort of patients treated by meniscal repair and autologous platelet-rich fibrin matrix augment. Methods Patients with lateral parameniscal cyst undergoing arthroscopic meniscal repair and autologous platelet-rich fibrin matrix augment between 2016 and 2019 were retrospectively reviewed in March 2021. Inclusion criteria were absence of prior surgery on the affected knee with minimum 2-year of follow-up. Exclusion criteria were concomitant ligament lesions, rheumatic diseases and knee osteoarthritis. After reviewing the database, each selected patient was contacted and asked to participate in the study; at the follow-up evaluation all patient signed an informed consent. Tegner-Lysholm knee score, IKDC and NRS were collected before surgery and at follow-up. Results This study included 15 patients (8 male) with mean age of 32.8 years old. No recurrence of the cysts was observed. The Tegner-Lysholm knee score and IKDC subjective scores increased respectively from 41.3 ± 5.4 and 37.6 ± 5.1 at baseline to 92.3 ± 4.6 and 89.4 ± 2.6 at the final follow up. Concerning pain relief, the Numeric Pain Rating Scale (NRS) displayed a significant improvement reaching at the follow up a score of 1,3 ± 1.1 in comparison to 6.8 ± 0.9 at the baseline. Conclusion Surgical management of symptomatic lateral parameniscal cyst with cyst excision, autologous PRP membrane application and meniscus repair demonstrated excellent subjective clinical outcome with any cyst reoccurrence. Level of evidence III, retrospective cohort study.Daniele ScrepisGianluca PiovanSimone NataliStefano PasqualottoStefano MagnanelliVenanzio IaconoLuca FarinelliMarco GrassiClaudio ZorziSpringerOpenarticleParameniscal cyst, PRP membraneAll-inside suturePRP augmentationOrthopedic surgeryRD701-811ENJournal of Experimental Orthopaedics, Vol 8, Iss 1, Pp 1-8 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Parameniscal cyst, PRP membrane All-inside suture PRP augmentation Orthopedic surgery RD701-811
spellingShingle	Parameniscal cyst, PRP membrane All-inside suture PRP augmentation Orthopedic surgery RD701-811 Daniele Screpis Gianluca Piovan Simone Natali Stefano Pasqualotto Stefano Magnanelli Venanzio Iacono Luca Farinelli Marco Grassi Claudio Zorzi The use of autologous platelet-rich fibrin matrix combined with meniscal repair in the treatment of parameniscal cyst: clinical results and cyst recurrence after 2-year of follow up
description	Abstract Purpose Parameniscal cysts are associate with horizontal meniscal tears. Arthroscopic meniscal repair and the excision of the cyst by mini-open approach represent a valid treatment. However, the recurrence of cyst is still a current issue. Therefore, biological factors may be considered to promote the biological repair and avoid recurrence. The aim of the present study was to report the clinical results and the rate of recurrence of the cyst after minimum 2-year of follow up in a cohort of patients treated by meniscal repair and autologous platelet-rich fibrin matrix augment. Methods Patients with lateral parameniscal cyst undergoing arthroscopic meniscal repair and autologous platelet-rich fibrin matrix augment between 2016 and 2019 were retrospectively reviewed in March 2021. Inclusion criteria were absence of prior surgery on the affected knee with minimum 2-year of follow-up. Exclusion criteria were concomitant ligament lesions, rheumatic diseases and knee osteoarthritis. After reviewing the database, each selected patient was contacted and asked to participate in the study; at the follow-up evaluation all patient signed an informed consent. Tegner-Lysholm knee score, IKDC and NRS were collected before surgery and at follow-up. Results This study included 15 patients (8 male) with mean age of 32.8 years old. No recurrence of the cysts was observed. The Tegner-Lysholm knee score and IKDC subjective scores increased respectively from 41.3 ± 5.4 and 37.6 ± 5.1 at baseline to 92.3 ± 4.6 and 89.4 ± 2.6 at the final follow up. Concerning pain relief, the Numeric Pain Rating Scale (NRS) displayed a significant improvement reaching at the follow up a score of 1,3 ± 1.1 in comparison to 6.8 ± 0.9 at the baseline. Conclusion Surgical management of symptomatic lateral parameniscal cyst with cyst excision, autologous PRP membrane application and meniscus repair demonstrated excellent subjective clinical outcome with any cyst reoccurrence. Level of evidence III, retrospective cohort study.
format	article
author	Daniele Screpis Gianluca Piovan Simone Natali Stefano Pasqualotto Stefano Magnanelli Venanzio Iacono Luca Farinelli Marco Grassi Claudio Zorzi
author_facet	Daniele Screpis Gianluca Piovan Simone Natali Stefano Pasqualotto Stefano Magnanelli Venanzio Iacono Luca Farinelli Marco Grassi Claudio Zorzi
author_sort	Daniele Screpis
title	The use of autologous platelet-rich fibrin matrix combined with meniscal repair in the treatment of parameniscal cyst: clinical results and cyst recurrence after 2-year of follow up
title_short	The use of autologous platelet-rich fibrin matrix combined with meniscal repair in the treatment of parameniscal cyst: clinical results and cyst recurrence after 2-year of follow up
title_full	The use of autologous platelet-rich fibrin matrix combined with meniscal repair in the treatment of parameniscal cyst: clinical results and cyst recurrence after 2-year of follow up
title_fullStr	The use of autologous platelet-rich fibrin matrix combined with meniscal repair in the treatment of parameniscal cyst: clinical results and cyst recurrence after 2-year of follow up
title_full_unstemmed	The use of autologous platelet-rich fibrin matrix combined with meniscal repair in the treatment of parameniscal cyst: clinical results and cyst recurrence after 2-year of follow up
title_sort	use of autologous platelet-rich fibrin matrix combined with meniscal repair in the treatment of parameniscal cyst: clinical results and cyst recurrence after 2-year of follow up
publisher	SpringerOpen
publishDate	2021
url	https://doaj.org/article/cb33ebd17fe148f987b2809e794321cd
work_keys_str_mv	AT danielescrepis theuseofautologousplateletrichfibrinmatrixcombinedwithmeniscalrepairinthetreatmentofparameniscalcystclinicalresultsandcystrecurrenceafter2yearoffollowup AT gianlucapiovan theuseofautologousplateletrichfibrinmatrixcombinedwithmeniscalrepairinthetreatmentofparameniscalcystclinicalresultsandcystrecurrenceafter2yearoffollowup AT simonenatali theuseofautologousplateletrichfibrinmatrixcombinedwithmeniscalrepairinthetreatmentofparameniscalcystclinicalresultsandcystrecurrenceafter2yearoffollowup AT stefanopasqualotto theuseofautologousplateletrichfibrinmatrixcombinedwithmeniscalrepairinthetreatmentofparameniscalcystclinicalresultsandcystrecurrenceafter2yearoffollowup AT stefanomagnanelli theuseofautologousplateletrichfibrinmatrixcombinedwithmeniscalrepairinthetreatmentofparameniscalcystclinicalresultsandcystrecurrenceafter2yearoffollowup AT venanzioiacono theuseofautologousplateletrichfibrinmatrixcombinedwithmeniscalrepairinthetreatmentofparameniscalcystclinicalresultsandcystrecurrenceafter2yearoffollowup AT lucafarinelli theuseofautologousplateletrichfibrinmatrixcombinedwithmeniscalrepairinthetreatmentofparameniscalcystclinicalresultsandcystrecurrenceafter2yearoffollowup AT marcograssi theuseofautologousplateletrichfibrinmatrixcombinedwithmeniscalrepairinthetreatmentofparameniscalcystclinicalresultsandcystrecurrenceafter2yearoffollowup AT claudiozorzi theuseofautologousplateletrichfibrinmatrixcombinedwithmeniscalrepairinthetreatmentofparameniscalcystclinicalresultsandcystrecurrenceafter2yearoffollowup AT danielescrepis useofautologousplateletrichfibrinmatrixcombinedwithmeniscalrepairinthetreatmentofparameniscalcystclinicalresultsandcystrecurrenceafter2yearoffollowup AT gianlucapiovan useofautologousplateletrichfibrinmatrixcombinedwithmeniscalrepairinthetreatmentofparameniscalcystclinicalresultsandcystrecurrenceafter2yearoffollowup AT simonenatali useofautologousplateletrichfibrinmatrixcombinedwithmeniscalrepairinthetreatmentofparameniscalcystclinicalresultsandcystrecurrenceafter2yearoffollowup AT stefanopasqualotto useofautologousplateletrichfibrinmatrixcombinedwithmeniscalrepairinthetreatmentofparameniscalcystclinicalresultsandcystrecurrenceafter2yearoffollowup AT stefanomagnanelli useofautologousplateletrichfibrinmatrixcombinedwithmeniscalrepairinthetreatmentofparameniscalcystclinicalresultsandcystrecurrenceafter2yearoffollowup AT venanzioiacono useofautologousplateletrichfibrinmatrixcombinedwithmeniscalrepairinthetreatmentofparameniscalcystclinicalresultsandcystrecurrenceafter2yearoffollowup AT lucafarinelli useofautologousplateletrichfibrinmatrixcombinedwithmeniscalrepairinthetreatmentofparameniscalcystclinicalresultsandcystrecurrenceafter2yearoffollowup AT marcograssi useofautologousplateletrichfibrinmatrixcombinedwithmeniscalrepairinthetreatmentofparameniscalcystclinicalresultsandcystrecurrenceafter2yearoffollowup AT claudiozorzi useofautologousplateletrichfibrinmatrixcombinedwithmeniscalrepairinthetreatmentofparameniscalcystclinicalresultsandcystrecurrenceafter2yearoffollowup
_version_	1718372103477002240

The use of autologous platelet-rich fibrin matrix combined with meniscal repair in the treatment of parameniscal cyst: clinical results and cyst recurrence after 2-year of follow up

Ejemplares similares